Effects of Chronic Pindolol Treatment on Human Myocardial Beta 1- and Beta 2-adrenoceptor Function

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1990 Oct 1

PMID 2175014

Authors

R Bjornerheim

S Golf

V Hansson

Affiliations

Soon will be listed here.

Abstract

To evaluate the effects of chronic pindolol treatment on human myocardial beta-adrenoceptor, membrane preparations from right atrial auricles from patients on chronic pindolol treatment and from patients not treated with beta-blocker were compared with respect to specific binding of [125I]-iodocyanopindolol [( 125I]-ICYP) and adenylate cyclase (AC) activity. Pindolol treatment was associated with a 25% increase in total beta-adrenoceptor density (72.3 vs. 58.3 fmol/mg protein). This increase was due a 40% increase of the beta 1-adrenoceptor subtype (62.2 vs. 44.3 fmol/mg protein), while beta 2-adrenoceptor density was decreased by about 25% (10.0 vs. 14.0 fmol/mg). Isoprenaline 5 mumol/l (9.7 vs. 14.2 pmol/min/mg) and terbutaline 50 mumol/l (4.9 vs. 8.3 pmol/min/mg protein) stimulated adenylate cyclase activity was reduced, whereas fluoride (10 mmol/l) stimulated cAMP production to the same extent in both groups (9.4 vs 9.4 pmol/min/mg protein). Thus, chronic treatment with pindolol was associated with upregulation of the beta 1-adrenoceptors and a down-regulation of the beta 2-adrenoceptors. The total level of beta-adrenoceptors was slightly increased. In spite of this, adenylate cyclase activity and response was reduced.

References

Gille E, Lemoine H, Ehle B, Kaumann A . The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(1):60-70. DOI: 10.1007/BF00498852. View

Abrahamsson T . The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat. Br J Pharmacol. 1986; 87(4):657-64. PMC: 1916803. DOI: 10.1111/j.1476-5381.1986.tb14582.x. View

Hedberg A, Gerber J, Nies A, Wolfe B, Molinoff P . Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986; 239(1):117-23. View

Birnbaumer L, Yang P, Hunzicker-Dunn M, Bockaert J, Duran J . Adenylyl cyclase activities in ovarian tissues. I. Homogenization and conditions of assay in graafian follicles and corpora lutea of rabbits, rats, and pigs: regulation by ATP, and some comparative properties. Endocrinology. 1976; 99(1):163-84. DOI: 10.1210/endo-99-1-163. View

Bristow M, Ginsburg R, Minobe W, Cubicciotti R, Sageman W, Lurie K . Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982; 307(4):205-11. DOI: 10.1056/NEJM198207223070401. View

Bristow M, Hershberger R, Port J, Minobe W, Rasmussen R . Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989; 35(3):295-303. View

Lefkowitz R, Caron M, Stiles G . Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. N Engl J Med. 1984; 310(24):1570-9. DOI: 10.1056/NEJM198406143102406. View

Emorine L, Marullo S, Patey G, Tate K, DELAVIER-KLUTCHKO C, Strosberg A . Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989; 245(4922):1118-21. DOI: 10.1126/science.2570461. View

Reithmann C, Wieland F, Jakobs K, Werdan K . Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors. Eur J Pharmacol. 1989; 170(3):243-55. DOI: 10.1016/0014-2999(89)90545-1. View

10.

Golf S, Hansson V . Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?. Scand J Clin Lab Invest. 1986; 46(2):121-30. DOI: 10.3109/00365518609083647. View

11.

van den Meiracker A, Man int Veld A, Boomsma F, Fischberg D, Molinoff P, SCHALEKAMP M . Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 1989; 80(4):903-14. DOI: 10.1161/01.cir.80.4.903. View

12.

Kaumann A . Is there a third heart beta-adrenoceptor?. Trends Pharmacol Sci. 1989; 10(8):316-20. DOI: 10.1016/0165-6147(89)90065-5. View

13.

Golf S, Hansson V . Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation. Cardiovasc Res. 1986; 20(9):637-44. DOI: 10.1093/cvr/20.9.637. View

14.

Golf S, Lovstad R, Hansson V . Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard. Cardiovasc Res. 1985; 19(10):636-41. DOI: 10.1093/cvr/19.10.636. View

15.

White A, Zenser T . Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase. Anal Biochem. 1971; 41(2):372-96. DOI: 10.1016/0003-2697(71)90156-4. View

16.

Michel M, Pingsmann A, Beckeringh J, Zerkowski H, Doetsch N, Brodde O . Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Br J Pharmacol. 1988; 94(3):685-92. PMC: 1854050. DOI: 10.1111/j.1476-5381.1988.tb11576.x. View

17.

Taylor S . Intrinsic sympathomimetic activity: clinical fact or fiction?. Am J Cardiol. 1983; 52(9):16D-26D. DOI: 10.1016/0002-9149(83)90638-0. View

18.

Kaumann A, Lobnig B . Mode of action of (-)-pindolol on feline and human myocardium. Br J Pharmacol. 1986; 89(1):207-18. PMC: 1917032. DOI: 10.1111/j.1476-5381.1986.tb11137.x. View

19.

Jasper J, Michel M, Insel P . Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists. Mol Pharmacol. 1990; 37(1):44-9. View

20.

Kaumann A, Lemoine H . Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(4):403-11. DOI: 10.1007/BF00165555. View